We are live on ! Find out more
LAB icon

Standard BioTools

104 hedge funds and large institutions have $1.29B invested in Standard BioTools in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 36 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

26% more capital invested

Capital invested by funds: $1.02B → $1.29B (+$264M)

11% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 36

4% more funds holding

Funds holding: 100104 (+4)

32% less call options, than puts

Call options by funds: $1.09M | Put options by funds: $1.6M

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
104
Holders Change
+4
Holders Change %
+4%
% of All Funds
2.77%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
16
Increased
40
Reduced
36
Closed
11
Calls
$1.09M
Puts
$1.6M
Net Calls
-$504K
Net Calls Change
-$141K
Name Holding Trade Value Shares
Change
Change in
Stake
Primecap Management
1
Primecap Management
California
$157M -$39.5K -1,000 -0%
Jennison Associates
2
Jennison Associates
New York
$128M -$2.25M -56,885 -2%
JP Morgan Chase
3
JP Morgan Chase
New York
$113M -$9.96M -252,056 -9%
Franklin Resources
4
Franklin Resources
California
$91.1M +$6.27M +158,556 +8%
O
5
OrbiMed
New York
$89.9M
WA
6
Wasatch Advisors
Utah
$86.1M +$2.05M +51,872 +3%
Lord, Abbett & Co
7
Lord, Abbett & Co
New Jersey
$66.7M +$15.6M +393,721 +33%
NCGI
8
Next Century Growth Investors
Minnesota
$56.9M -$6.71M -169,728 -11%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$48.6M -$3.17M -80,200 -7%
Vanguard Group
10
Vanguard Group
Pennsylvania
$39.9M +$2.21M +55,790 +6%
RIM
11
RS Investment Management
California
$38.3M +$4.58M +115,970 +15%
BFA
12
BlackRock Fund Advisors
California
$36.8M -$123K -3,099 -0.4%
Schroder Investment Management Group
13
Schroder Investment Management Group
United Kingdom
$29.7M +$806K +20,400 +3%
RG
14
Redmile Group
California
$23.7M -$1.9M -48,005 -8%
BIT
15
BlackRock Institutional Trust
California
$22.8M +$6.12M +154,837 +40%
State Street
16
State Street
Massachusetts
$18.7M +$947K +23,955 +6%
Invesco
17
Invesco
Georgia
$17M -$4.08M -103,083 -20%
Northern Trust
18
Northern Trust
Illinois
$16.9M +$2.19M +55,354 +16%
Luther King Capital Management (LKCM)
19
Luther King Capital Management (LKCM)
Texas
$16.6M -$6.73M -170,235 -30%
Lazard Asset Management
20
Lazard Asset Management
New York
$13.3M +$2.21M +55,860 +22%
RFC
21
Russell Frank Company
Washington
$12.7M +$2.67M +67,652 +29%
Deutsche Bank
22
Deutsche Bank
Germany
$11M +$3.18M +80,501 +45%
SIMG
23
Stephens Investment Management Group
Texas
$10.9M -$1.67M -42,124 -14%
SCM
24
Sandler Capital Management
New York
$10.3M +$37.2K +940 +0.4%
GIP
25
Granite Investment Partners
California
$7.99M +$4.83M +122,068 +181%

LAB Hedge Fund Activity: Q1 2015 in Review

104 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2015, worth a combined $1.29B — up 26% from $1.02B a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new LAB positions and 11 closed out — a net gain of 5 holders — while 40 added to existing stakes and 36 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $15.6M. The largest seller was JP Morgan Chase, cutting an estimated $9.96M.

  • 104 institutional investors held Standard BioTools (LAB) as of Q1 2015, up from 100 in Q4 2014.
  • Funds reported $1.29B of Standard BioTools stock for Q1 2015, up 26% quarter-over-quarter.
  • 16 funds opened new Standard BioTools positions in Q1 2015 and 11 closed out, a net change of +5 holders.
  • The largest Standard BioTools buyer in Q1 2015 was Lord, Abbett & Co, an estimated $15.6M added.
  • The largest Standard BioTools seller in Q1 2015 was JP Morgan Chase, an estimated $9.96M sold.

Based on aggregated 13F filings for Q1 2015.